Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00024 | 1 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -7.2e-05 | 1 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | 5.7e-06 | 1 |